CRNX

Crinetics Pharmaceuticals, Inc.

55.95

USD

CRNX Earnings Reports

Positive Surprise Ratio

CRNX beat 7 of 30 last estimates.

23%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$4.64M

-$1.38

Implied change from Q3 25 (Revenue/ EPS)

+3144.33%

Implied change from Q4 24 (Revenue/ EPS)

+56.82%

Crinetics Pharmaceuticals, Inc. earnings per share and revenue

On Nov 06, 2025, CRNX reported earnings of -1.38 USD per share (EPS) for Q3 25, missing the estimate of -1.28 USD, resulting in a -7.75% surprise. Revenue reached 143.00 thousand, compared to an expected 370.89 thousand, with a -61.44% difference. The market reacted with a -8.02% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 17 analysts forecast an EPS of -1.38 USD, with revenue projected to reach 4.64 million USD, implying an increase of 0.00% EPS, and increase of 3144.33% in Revenue from the last quarter.

FAQ

What were Crinetics Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Crinetics Pharmaceuticals, Inc. reported EPS of -$1.38, missing estimates by -7.75%, and revenue of $143.00K, -61.44% below expectations.

How did the market react to Crinetics Pharmaceuticals, Inc.'s Q3 2025 earnings?

The stock price moved down -8.02%, changed from $43.49 before the earnings release to $40.00 the day after.

When is Crinetics Pharmaceuticals, Inc. expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Crinetics Pharmaceuticals, Inc.'s next earnings report?

Based on 17 analysts, Crinetics Pharmaceuticals, Inc. is expected to report EPS of -$1.38 and revenue of $4.64M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.